CTI 102 (Diclofenac sodium delayed release 50 mg)

Pill imprint CTI 102 has been identified as Diclofenac sodium delayed release 50 mg.

Diclofenac is used in the treatment of back pain; frozen shoulder; muscle pain; ankylosing spondylitis; pain (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. There is positive evidence of human fetal risk during pregnancy. Diclofenac 50 mg is not a controlled substance under the Controlled Substance Act (CSA).

Diclofenac sodium delayed release

Imprint:

CTI 102

Strength:

50 mg

Color:

White

Shape:

Round

Availability:

Prescription only

Drug Class:

Nonsteroidal anti-inflammatory agents

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Carlsbad Technology, Inc.

National Drug Code (NDC):

61442-0102

Inactive Ingredients:

ferrosoferric oxide
hypromelloses
lactose monohydrate
magnesium stearate
methacrylic acid - methyl methacrylate copolymer (1:1)
microcrystalline cellulose
shellac
povidone
sodium starch glycolate type A potato
magnesium silicate
titanium dioxide

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
42291-0230	AvKare, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.